Centre for Diagnostic, Therapeutic and Investigative Studies, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
All Life Advance Immunology Sdn. Bhd., Petaling Jaya, Selangor, Malaysia.
Methods Mol Biol. 2024;2736:65-76. doi: 10.1007/7651_2022_477.
Hematopoiesis is maintained throughout life from the hematopoietic stem cell niche in which hematopoietic stem cells and lineage-specific hematopoietic progenitors (HSPCs) reside and regulate hematopoiesis. Meanwhile, HSPCs behavior is modulated by both cell intrinsic (e.g., transcriptional factors) and cell extrinsic (e.g., cytokines) factors. Dysregulation of these factors can alter HSPCs function, leading to disrupted hematopoiesis, cellular changes, and subsequent hematological diseases and malignancies. Moreover, it has been reported that chromosomal aberration (CA) in HSPCs following exposure to carcinogenic or genotoxic agents can initiate leukemia stem cells (LSCs) formation which lays a fundamental mechanism in leukemogenesis. Despite reported studies concerning the chromosomal integrity in HSPCs, CA analysis in lineage-specific HSPCs remains scarce. This indicates a need for a laboratory technique that allows the study of CA in specific HSPCs subpopulations comprising differential hematopoietic lineages. Thus, this chapter focuses on the structural (clastogenicity) and numerical (aneugenicity) form of CA analysis in lineage-specific HSPCs comprised of myeloid, erythroid and lymphoid lineages.In this protocol, we describe how to perform CA analysis in lineage-specific HSPCs derived from freshly isolated mouse bone marrow cells (MBMCs) using the combined techniques of colony-forming unit (CFU) and karyotyping. Prior to CA analysis, lineage-specific HSPCs for myeloid, erythroid, and lymphoid were enriched through colony-forming unit (CFU) assay. CFU assay assesses the proliferative ability and differentiation potential of an individual HSPC within a sample. About 6 to 14 days of cultures are required depending on the type of HSPCs lineage. The optimal duration is crucial to achieve sufficient colony growth that is needed for accurate CFU analysis via morphological identification and colony counting. Then, the CA focusing on clastogenicity and aneugenicity anomalies in respective HSPCs lineage for myeloid, erythroid and Pre-B lymphoid were investigated. The resulted karyotypes were classified according to the types of CA known as Robertsonian (Rb) translocation, hyperploidy or complex. We believe our protocol offers a significant contribution to be utilized as a reference method for chromosomal analysis in lineage-specific HSPCs subpopulations.
造血是由造血干细胞龛维持的,造血干细胞和谱系特异性造血祖细胞(HSPCs)存在于其中,并调节造血。同时,HSPCs 的行为受到细胞内在(例如转录因子)和细胞外在(例如细胞因子)因素的调节。这些因素的失调会改变 HSPCs 的功能,导致造血功能紊乱、细胞变化,随后发展为血液系统疾病和恶性肿瘤。此外,据报道,暴露于致癌或遗传毒性剂后的 HSPC 中的染色体异常(CA)可引发白血病干细胞(LSCs)的形成,这为白血病发生奠定了基本机制。尽管有关于 HSPC 中染色体完整性的报道研究,但谱系特异性 HSPC 中的 CA 分析仍然很少。这表明需要一种实验室技术,允许研究特定的 HSPC 亚群中的 CA,这些亚群包含不同的造血谱系。因此,本章重点介绍了骨髓细胞(MBMCs)中分化的骨髓、红细胞和淋巴细胞谱系特异性 HSPCs 的结构性(致裂原性)和数值性(非整倍性)CA 分析。在本方案中,我们描述了如何使用集落形成单位(CFU)和核型分析相结合的技术,从新鲜分离的小鼠骨髓细胞(MBMCs)中分离出的谱系特异性 HSPCs 中进行 CA 分析。在 CA 分析之前,通过集落形成单位(CFU)测定法对骨髓、红细胞和淋巴谱系的特异性 HSPC 进行了富集。CFU 测定法评估了单个 HSPC 在样品中的增殖能力和分化潜力。根据 HSPC 谱系的类型,培养时间需要 6 到 14 天。最佳持续时间对于获得足够的集落生长至关重要,这是通过形态学鉴定和集落计数进行准确 CFU 分析所必需的。然后,研究了骨髓、红细胞和 Pre-B 淋巴谱系特异性 HSPCs 中分别致裂原性和非整倍性异常的 CA。根据已知的 CA 类型(罗氏易位、超二倍体或复杂)对得到的核型进行分类。我们相信,我们的方案为在谱系特异性 HSPC 亚群中进行染色体分析提供了一种有价值的参考方法。